GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Additional Paid-In Capital

GeneOne Life Science (XKRX:011000) Additional Paid-In Capital : ₩217,579 Mil(As of Sep. 2024)


View and export this data going back to 1987. Start your Free Trial

What is GeneOne Life Science Additional Paid-In Capital?


GeneOne Life Science's quarterly additional paid-in capital increased from Mar. 2024 (₩217,579 Mil) to Jun. 2024 (₩217,579 Mil) but then stayed the same from Jun. 2024 (₩217,579 Mil) to Sep. 2024 (₩217,579 Mil).

GeneOne Life Science's annual additional paid-in capital increased from Dec. 2021 (₩209,871 Mil) to Dec. 2022 (₩214,299 Mil) and increased from Dec. 2022 (₩214,299 Mil) to Dec. 2023 (₩215,555 Mil).


GeneOne Life Science Additional Paid-In Capital Historical Data

The historical data trend for GeneOne Life Science's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneOne Life Science Additional Paid-In Capital Chart

GeneOne Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45,251.27 117,318.58 209,871.03 214,298.76 215,554.93

GeneOne Life Science Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215,566.61 215,554.93 217,579.41 217,579.41 217,579.41

GeneOne Life Science Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

GeneOne Life Science Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of GeneOne Life Science's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneOne Life Science Business Description

Traded in Other Exchanges
N/A
Address
343, Hakdong-ro, Gangnam-Gu, Seoul, KOR
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.

GeneOne Life Science Headlines

No Headlines